A newly approved drug for type 2 diabetes and kidney disease, sotagliflozin, has shown remarkable benefits in reducing the ...

Health groups tackle apprehension online towards vaccines, which the health ministry is giving out for free to senior ...

"Heart failure and kidney failure often go hand in hand," he told Newsweek, adding that the kidneys control the way the body handles salt and water. If they are not getting rid of these substances ...

Dr. Philip A. Chan joined GoLocal to discuss the new wave of weight loss drugs and their implications for fighting obesity as well as their implications for other applications like kidney disease and ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

In a powerful act of love and sacrifice, Julie Malliet donated her kidney to her husband, Dave, who had been battling chronic kidney disease for years.

Cardiovascular diseases claim more lives in the U.S. than all forms of cancer and accidental deaths combined, according to ...

A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

Successful petitions to receive compassionate early release from federal prisons due to health issues are rare. They are even ...

Observational data fill a knowledge gap in the absence of randomized trials comparing empagliflozin vs dapagliflozin in patients with type 2 diabetes.

Humana and Monogram Health, a value-based multispecialty provider of in-home care and benefit management services for patients living with kidney disease, have expanded their partnership to patients ...